0001104659-16-107167.txt : 20160323 0001104659-16-107167.hdr.sgml : 20160323 20160323163106 ACCESSION NUMBER: 0001104659-16-107167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160322 FILED AS OF DATE: 20160323 DATE AS OF CHANGE: 20160323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nivalis Therapeutics, Inc. CENTRAL INDEX KEY: 0001626199 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208969493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-945-7700 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Congleton Jon CENTRAL INDEX KEY: 0001644975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37449 FILM NUMBER: 161524241 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 4 1 a4.xml 4 X0306 4 2016-03-22 0 0001626199 Nivalis Therapeutics, Inc. NVLS 0001644975 Congleton Jon C/O NIVALIS THERAPEUTICS, INC. 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 1 1 0 0 President and CEO Common Stock 2016-03-22 4 P 0 5000 4.3815 A 10000 D The price recorded in Column 4 represents the actual price for the full block purchase. /s/ R. Michael Carruthers, Attorney-in-Fact 2016-03-23